The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir

The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir

<b><i>Background:</i></b> The results of long-term renal evolution in HCV-infected patients using sofosbuvir and velpatasvir (SOF/VEL), with or without ribavirin (RBV), are lacking. <b><i>Aims:</i></b> We evaluated the renal safety for HCV-infected pat...

Full description

Bibliographic Details
Main Authors: Cheng-Kun Wu, Li-Wei Chen, Te-Sheng Chang, Shui-Yi Tung, Chun-Yen Lin, Chao-Hung Hung, Sheng-Nan Lu, Chih-Lang Lin, Chien-Hung Chen, Chao-Wei Hsu, Tsung-Hui Hu, I-Shyan Sheen
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Viruses
Subjects:
direct-acting antivirals
hepatitis C virus
sofosbuvir and velpatasvir
renal function
Online Access:https://www.mdpi.com/1999-4915/14/2/362

Internet

https://www.mdpi.com/1999-4915/14/2/362

Similar Items